Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) with [(177)Lu]-DOTA-TATE is an effective treatment of neuroendocrine tumors (NETs). After each cycle of treatment, patient dosimetry evaluates the radiation dose to the risk organs, kidneys, and bone marrow, the most radiosensitive tissues. Ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Chicheportiche, Alexandre, Artoul, Faozi, Schwartz, Arnon, Grozinsky-Glasberg, Simona, Meirovitz, Amichay, Gross, David J., Godefroy, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006002/
https://www.ncbi.nlm.nih.gov/pubmed/29916115
http://dx.doi.org/10.1186/s40658-018-0211-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006002/
https://www.ncbi.nlm.nih.gov/pubmed/29916115
http://dx.doi.org/10.1186/s40658-018-0211-1

Ejemplares similares